Innoviva (INVA) News Today $21.69 +0.29 (+1.36%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$21.68 -0.02 (-0.07%) As of 06/13/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Innoviva Specialty's gonorrhea antibiotic to undergo FDA reviewJune 10, 2025 | msn.comInnoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in AdultsJune 10, 2025 | businesswire.comInnoviva: A Riddle Wrapped In A Mystery Inside An EnigmaJune 8, 2025 | seekingalpha.comGAMMA Investing LLC Acquires 77,145 Shares of Innoviva, Inc. (NASDAQ:INVA)GAMMA Investing LLC increased its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 1,751.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 81,549 shares of the biotechnology company's stock afterJune 7, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Sets New 1-Year High - Time to Buy?Innoviva (NASDAQ:INVA) Hits New 1-Year High - Still a Buy?June 6, 2025 | marketbeat.comTheravance Biopharma’s Hold Rating: Balancing Cash Influx with Long-term Growth UncertaintyJune 5, 2025 | tipranks.comTheravance Biopharma Sells Trelegy Royalty Interest to GSKJune 2, 2025 | tipranks.comNuveen Asset Management LLC Has $5.32 Million Position in Innoviva, Inc. (NASDAQ:INVA)Nuveen Asset Management LLC raised its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 87.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 306,562 shares of the biotechnology company's stock after purcJune 1, 2025 | marketbeat.comTwo Sigma Investments LP Has $4.56 Million Stock Position in Innoviva, Inc. (NASDAQ:INVA)Two Sigma Investments LP reduced its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 45.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 262,739 shares of the bMay 29, 2025 | marketbeat.comJefferies Financial Group Inc. Has $5.14 Million Stake in Innoviva, Inc. (NASDAQ:INVA)Jefferies Financial Group Inc. lifted its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 355.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 296,238 shares of the biotechnology comMay 28, 2025 | marketbeat.comTwo Sigma Advisers LP Lowers Stock Position in Innoviva, Inc. (NASDAQ:INVA)Two Sigma Advisers LP lowered its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 45.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 204,500 shares of the biotechnology company's stock after selling 173,800 shares dMay 28, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Stock Holdings Lifted by Millennium Management LLCMillennium Management LLC grew its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 426.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 400,613 shares of the biotechnology company's stock afterMay 28, 2025 | marketbeat.comBank of America Corp DE Decreases Holdings in Innoviva, Inc. (NASDAQ:INVA)Bank of America Corp DE decreased its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 5.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,063,864 shares of the biotechnology company's stock afterMay 23, 2025 | marketbeat.comMan Group plc Acquires 81,891 Shares of Innoviva, Inc. (NASDAQ:INVA)Man Group plc raised its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 20.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 486,869 shares of the biotechnology company's stock after acquiring an additional 81,May 21, 2025 | marketbeat.comTheravance Biopharma Holds 2025 Annual General MeetingMay 20, 2025 | tipranks.comZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial InfectionsMay 20, 2025 | businesswire.comBalyasny Asset Management L.P. Takes $277,000 Position in Innoviva, Inc. (NASDAQ:INVA)Balyasny Asset Management L.P. purchased a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 15,968 shares of the bioteMay 20, 2025 | marketbeat.comBasilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United StatesMay 20, 2025 | globenewswire.comSystematic Financial Management LP Has $35.20 Million Holdings in Innoviva, Inc. (NASDAQ:INVA)Systematic Financial Management LP lifted its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,029,069 shares of the biotechnology coMay 19, 2025 | marketbeat.comComerica Bank Sells 141,150 Shares of Innoviva, Inc. (NASDAQ:INVA)Comerica Bank lowered its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 87.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 20,269 shares of the biotechnology company's stock after selling 141,150 shares during the periMay 19, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Bought by Northern Trust CorpNorthern Trust Corp increased its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 4.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 679,044 shares of the biotechnology company's stock after purMay 19, 2025 | marketbeat.com21,999 Shares in Innoviva, Inc. (NASDAQ:INVA) Purchased by Occudo Quantitative Strategies LPOccudo Quantitative Strategies LP purchased a new position in Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 21,999 shares of the biotechnology company's stock,May 18, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Bought by D. E. Shaw & Co. Inc.D. E. Shaw & Co. Inc. grew its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 28.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 842,647 shares of the biotechnology company's stock after acquiring an additionalMay 16, 2025 | marketbeat.comJefferies Financial Group Inc. Has $5.14 Million Position in Innoviva, Inc. (NASDAQ:INVA)Jefferies Financial Group Inc. raised its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 355.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 296,238 shares of the biotechnology company's stock after buying an addiMay 15, 2025 | marketbeat.com16,198 Shares in Innoviva, Inc. (NASDAQ:INVA) Purchased by Brevan Howard Capital Management LPBrevan Howard Capital Management LP purchased a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 16,198 shares of the biotechnology company's stock,May 14, 2025 | marketbeat.comTheravance Biopharma to Participate in an Upcoming Investor Conference | TBPH Stock NewsMay 13, 2025 | gurufocus.comJane Street Group LLC Purchases 194,270 Shares of Innoviva, Inc. (NASDAQ:INVA)Jane Street Group LLC raised its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 142.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 330,631 shares of the biotechnology company's stock after acquiring an additional 194,270May 12, 2025 | marketbeat.comBridgeway Capital Management LLC Has $3.23 Million Stake in Innoviva, Inc. (NASDAQ:INVA)Bridgeway Capital Management LLC lowered its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 42.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 185,859 shares of the biotechnology company's stock aftMay 11, 2025 | marketbeat.comTheravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress | ...May 9, 2025 | gurufocus.comTheravance Biopharma Inc (TBPH) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...May 9, 2025 | gurufocus.comInnoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are SellingMay 8, 2025 | msn.comSchonfeld Strategic Advisors LLC Purchases 14,957 Shares of Innoviva, Inc. (NASDAQ:INVA)Schonfeld Strategic Advisors LLC lifted its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 16.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,600 shares of the biotechnologyMay 8, 2025 | marketbeat.comInnoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company ProgressMay 7, 2025 | businesswire.comSusquehanna Fundamental Investments LLC Acquires New Stake in Innoviva, Inc. (NASDAQ:INVA)Susquehanna Fundamental Investments LLC bought a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 16,108 shares of the biotechnology company's stock, valued aMay 7, 2025 | marketbeat.comFreestone Grove Partners LP Invests $674,000 in Innoviva, Inc. (NASDAQ:INVA)Freestone Grove Partners LP acquired a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 38,825 shares of the biotechnology company's stock, vMay 6, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Upgraded at StockNews.comStockNews.com upgraded Innoviva from a "hold" rating to a "buy" rating in a research report on Wednesday.May 2, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Acquired by Dimensional Fund Advisors LPDimensional Fund Advisors LP boosted its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 4.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,919,518 shares of the biotechnology company's stock after acquiring an additional 226,592 shMay 2, 2025 | marketbeat.comHsbc Holdings PLC Invests $5.44 Million in Innoviva, Inc. (NASDAQ:INVA)Hsbc Holdings PLC bought a new position in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 313,029 shares of the biotechnology company's stock, valued at approximaMay 1, 2025 | marketbeat.comRep. George Whitesides Unloads Shares of Innoviva, Inc. (NASDAQ:INVA)Representative George Whitesides (D-California) recently sold shares of Innoviva, Inc. (NASDAQ:INVA). In a filing disclosed on April 23rd, the Representative disclosed that they had sold between $50,001 and $100,000 in Innoviva stock on March 24th. The trade occurred in the Representative's "GEORGEApril 28, 2025 | marketbeat.comRep. George Whitesides Sells Off Shares of Innoviva, Inc. (NASDAQ:INVA)Representative George Whitesides (D-California) recently sold shares of Innoviva, Inc. (NASDAQ:INVA). In a filing disclosed on April 23rd, the Representative disclosed that they had sold between $250,001 and $500,000 in Innoviva stock on March 25th. The trade occurred in the Representative's "LORETApril 28, 2025 | marketbeat.comMarshall Wace LLP Buys 178,583 Shares of Innoviva, Inc. (NASDAQ:INVA)Marshall Wace LLP raised its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 130.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 314,968 shares of the biotechnology company's stockApril 26, 2025 | marketbeat.comStockNews.com Downgrades Innoviva (NASDAQ:INVA) to HoldStockNews.com lowered shares of Innoviva from a "buy" rating to a "hold" rating in a report on Tuesday.April 23, 2025 | marketbeat.comInvesco Ltd. Has $18.25 Million Stock Holdings in Innoviva, Inc. (NASDAQ:INVA)Invesco Ltd. decreased its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 27.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,051,879 shares of the biotechnology company's stock afterApril 21, 2025 | marketbeat.comLSV Asset Management Has $696,000 Position in Innoviva, Inc. (NASDAQ:INVA)LSV Asset Management decreased its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 59.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,094 shares of the biotechnology company's stock after sellingApril 17, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Raised to Buy at StockNews.comStockNews.com upgraded Innoviva from a "hold" rating to a "buy" rating in a research report on Monday.April 16, 2025 | marketbeat.comRussell Investments Group Ltd. Decreases Stock Position in Innoviva, Inc. (NASDAQ:INVA)Russell Investments Group Ltd. cut its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 79.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 373,266 shares of the biotechnology company's stock afApril 15, 2025 | marketbeat.comNorges Bank Takes $1.48 Million Position in Innoviva, Inc. (NASDAQ:INVA)Norges Bank purchased a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 85,282 shares of the biotechnology company's stock, valued at approximately $1,480,0April 14, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC lowered its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,261,732 shares of the bioApril 12, 2025 | marketbeat.comVanguard Group Inc. Buys 84,934 Shares of Innoviva, Inc. (NASDAQ:INVA)Vanguard Group Inc. boosted its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 1.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,312,631 shares of the biotechnology company's stock after purchasinApril 10, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Sold by ExodusPoint Capital Management LPExodusPoint Capital Management LP decreased its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 59.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 138,689 shares of the bioteApril 9, 2025 | marketbeat.com Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address INVA Media Mentions By Week INVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INVA News Sentiment▼0.740.88▲Average Medical News Sentiment INVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INVA Articles This Week▼43▲INVA Articles Average Week Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alkermes News BioCryst Pharmaceuticals News Ligand Pharmaceuticals News Amicus Therapeutics News Celldex Therapeutics News MannKind News Dynavax Technologies News Novavax News OPKO Health News Geron News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INVA) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innoviva, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innoviva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INVA Stock Free INVA Stock Alerts